APO Research
Talk to an analyst

APO RESEARCH · REPORT

Androstenedione

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.

Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.

Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.

In the report, the data bases on androstenedione and androstadienedione.

Selected research

Industry Growth & Trends

Global Androstenedione Industry Growth and Trends Forecast to 2032

1 January 2026119 pages

Choose your research edition.

Industry ResearchAndrostenedione Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Androstenedione Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Androstenedione Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Androstenedione Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Androstenedione Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.

Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.

Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.

Read the full market overview

In the report, the data bases on androstenedione and androstadienedione.

Androstenedione production is concentrated relatively. Currently, there are several producing companies in the world androstenedione industry. The main market players are BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York and Jiufu. Tianjin King York is the leader in the global market, with about 16% market shares.

China is the largest production region and the share reached 77.68% in 2015. The shares of Europe, India and Asia Other were 11.51%, 2.58% and 2.79%.

Report Scope

This report provides a structured, data-driven view of the global Androstenedione market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Androstenedione market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Androstenedione market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Androstenedione.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Androstenedione market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Androstenedione Market by Company

BIOVET

Indo Phyto Chemicals

Sito Bio

Goto Pharmaceutical

Tianjin King York

Jiufu

Yongning Pharma

Jiangxi Hongyuan Pharmaceutical

Kaizon

Xi’an Gaoyuan Bio-Chem

Dongyao Pharmaceutical

Huazhong Pharmaceutical

Darui

Danjiangkou Danao

Dahua Pharmaceutical

Androstenedione Segment by Type

Androstenedione

Androstadienedione

Androstenedione Segment by Application

Arthritis Pharmaceuticals

Fertility Control Pharmaceuticals

Infectious Inflammation Pharmaceuticals

Others

Androstenedione Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androstenedione market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Androstenedione and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androstenedione.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Androstenedione manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Androstenedione in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Androstenedione Table 2. Major Company of Androstadienedione Table 3. Global Androstenedione Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Androstenedione Sales by Type (2021-2026) & (MT) Table 5. Global Androstenedione Sales Market Share in Volume by Type (2021-2026) Table 6. Global Androstenedione Sales by Type (2021-2026) & (US$ Million) Table 7. Global Androstenedione Sales Market Share in Value by Type (2021-2026) Table 8. Global Androstenedione Price by Type (2021-2026) & (USD/MT) Table 9. Global Androstenedione Sales by Type (2027-2032) & (MT) Table 10. Global Androstenedione Sales Market Share in Volume by Type (2027-2032) Table 11. Global Androstenedione Sales by Type (2027-2032) & (US$ Million) Table 12. Global Androstenedione Sales Market Share in Value by Type (2027-2032) Table 13. Global Androstenedione Price by Type (2027-2032) & (USD/MT) Table 14. North America Androstenedione Sales by Type (2021-2026) & (MT) Table 15. North America Androstenedione Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Androstenedione Sales by Type (2021-2026) & (MT) Table 17. Europe Androstenedione Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Androstenedione Sales by Type (2021-2026) & (MT) Table 19. Asia-Pacific Androstenedione Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Androstenedione Sales by Type (2021-2026) & (MT) Table 21. Latin America Androstenedione Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Androstenedione Sales by Type (2021-2026) & (MT) Table 23. Middle East and Africa Androstenedione Sales by Type (2021-2026) & (US$ Million) Table 24. Androstenedione Industry Trends Table 25. Androstenedione Industry Drivers Table 26. Androstenedione Industry Opportunities and Challenges Table 27. Androstenedione Industry Restraints Table 28. Global Androstenedione Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Androstenedione Revenue Market Share by Company (2021-2026) Table 30. Global Androstenedione Sales by Company (2021-2026) & (MT) Table 31. Global Androstenedione Sales Share by Company (2021-2026) Table 32. Global Androstenedione Market Price by Company (2021-2026) & (USD/MT) Table 33. Global Androstenedione Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Androstenedione Major Company Production Sites and Headquarters Table 35. Global Androstenedione Company, Product Type & Application Table 36. Global Androstenedione Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Androstenedione by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Androstenedione Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Androstenedione Sales by Region (2021-2026) & (MT) Table 41. Global Androstenedione Sales Market Share in Volume by Region (2021-2026) Table 42. Global Androstenedione Sales by Region (2021-2026) & (US$ Million) Table 43. Global Androstenedione Sales Market Share in Value by Region (2021-2026) Table 44. Global Androstenedione Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 45. Global Androstenedione Sales by Region (2027-2032) & (MT) Table 46. Global Androstenedione Sales Market Share in Volume by Region (2027-2032) Table 47. Global Androstenedione Sales by Region (2027-2032) & (US$ Million) Table 48. Global Androstenedione Sales Market Share in Value by Region (2027-2032) Table 49. Global Androstenedione Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 50. Global Androstenedione Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Androstenedione Sales by Application (2021-2026) & (MT) Table 52. Global Androstenedione Sales Market Share in Volume by Application (2021-2026) Table 53. Global Androstenedione Sales by Application (2021-2026) & (US$ Million) Table 54. Global Androstenedione Sales Market Share in Value by Application (2021-2026) Table 55. Global Androstenedione Price by Application (2021-2026) & (USD/MT) Table 56. Global Androstenedione Sales by Application (2027-2032) & (MT) Table 57. Global Androstenedione Sales Market Share in Volume by Application (2027-2032) Table 58. Global Androstenedione Sales by Application (2027-2032) & (US$ Million) Table 59. Global Androstenedione Sales Market Share in Value by Application (2027-2032) Table 60. Global Androstenedione Price by Application (2027-2032) & (USD/MT) Table 61. North America Androstenedione Sales by Application (2021-2026) & (MT) Table 62. North America Androstenedione Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Androstenedione Sales by Application (2021-2026) & (MT) Table 64. Europe Androstenedione Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Androstenedione Sales by Application (2021-2026) & (MT) Table 66. Asia-Pacific Androstenedione Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Androstenedione Sales by Application (2021-2026) & (MT) Table 68. Latin America Androstenedione Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Androstenedione Sales by Application (2021-2026) & (MT) Table 70. Middle East and Africa Androstenedione Sales by Application (2021-2026) & (US$ Million) Table 71. BIOVET Company Information Table 72. BIOVET Business Overview Table 73. BIOVET Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 74. BIOVET Androstenedione Product Portfolio Table 75. BIOVET Recent Development Table 76. Indo Phyto Chemicals Company Information Table 77. Indo Phyto Chemicals Business Overview Table 78. Indo Phyto Chemicals Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 79. Indo Phyto Chemicals Androstenedione Product Portfolio Table 80. Indo Phyto Chemicals Recent Development Table 81. Sito Bio Company Information Table 82. Sito Bio Business Overview Table 83. Sito Bio Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 84. Sito Bio Androstenedione Product Portfolio Table 85. Sito Bio Recent Development Table 86. Goto Pharmaceutical Company Information Table 87. Goto Pharmaceutical Business Overview Table 88. Goto Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 89. Goto Pharmaceutical Androstenedione Product Portfolio Table 90. Goto Pharmaceutical Recent Development Table 91. Tianjin King York Company Information Table 92. Tianjin King York Business Overview Table 93. Tianjin King York Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 94. Tianjin King York Androstenedione Product Portfolio Table 95. Tianjin King York Recent Development Table 96. Jiufu Company Information Table 97. Jiufu Business Overview Table 98. Jiufu Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 99. Jiufu Androstenedione Product Portfolio Table 100. Jiufu Recent Development Table 101. Yongning Pharma Company Information Table 102. Yongning Pharma Business Overview Table 103. Yongning Pharma Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 104. Yongning Pharma Androstenedione Product Portfolio Table 105. Yongning Pharma Recent Development Table 106. Jiangxi Hongyuan Pharmaceutical Company Information Table 107. Jiangxi Hongyuan Pharmaceutical Business Overview Table 108. Jiangxi Hongyuan Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 109. Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio Table 110. Jiangxi Hongyuan Pharmaceutical Recent Development Table 111. Kaizon Company Information Table 112. Kaizon Business Overview Table 113. Kaizon Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 114. Kaizon Androstenedione Product Portfolio Table 115. Kaizon Recent Development Table 116. Xi’an Gaoyuan Bio-Chem Company Information Table 117. Xi’an Gaoyuan Bio-Chem Business Overview Table 118. Xi’an Gaoyuan Bio-Chem Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 119. Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio Table 120. Xi’an Gaoyuan Bio-Chem Recent Development Table 121. Dongyao Pharmaceutical Company Information Table 122. Dongyao Pharmaceutical Business Overview Table 123. Dongyao Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 124. Dongyao Pharmaceutical Androstenedione Product Portfolio Table 125. Dongyao Pharmaceutical Recent Development Table 126. Huazhong Pharmaceutical Company Information Table 127. Huazhong Pharmaceutical Business Overview Table 128. Huazhong Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 129. Huazhong Pharmaceutical Androstenedione Product Portfolio Table 130. Huazhong Pharmaceutical Recent Development Table 131. Darui Company Information Table 132. Darui Business Overview Table 133. Darui Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 134. Darui Androstenedione Product Portfolio Table 135. Darui Recent Development Table 136. Danjiangkou Danao Company Information Table 137. Danjiangkou Danao Business Overview Table 138. Danjiangkou Danao Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 139. Danjiangkou Danao Androstenedione Product Portfolio Table 140. Danjiangkou Danao Recent Development Table 141. Dahua Pharmaceutical Company Information Table 142. Dahua Pharmaceutical Business Overview Table 143. Dahua Pharmaceutical Androstenedione Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 144. Dahua Pharmaceutical Androstenedione Product Portfolio Table 145. Dahua Pharmaceutical Recent Development Table 146. North America Androstenedione Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 147. North America Androstenedione Sales by Country (2021-2026) & (MT) Table 148. North America Androstenedione Sales Market Share by Country (2021-2026) Table 149. North America Androstenedione Sales Forecast by Country (2027-2032) & (MT) Table 150. North America Androstenedione Sales Market Share Forecast by Country (2027-2032) Table 151. North America Androstenedione Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Androstenedione Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Androstenedione Market Share by Country (2021-2026) Table 154. North America Androstenedione Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Androstenedione Market Share Forecast by Country (2027-2032) Table 156. Europe Androstenedione Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 157. Europe Androstenedione Sales by Country (2021-2026) & (MT) Table 158. Europe Androstenedione Sales Market Share by Country (2021-2026) Table 159. Europe Androstenedione Sales Forecast by Country (2027-2032) & (MT) Table 160. Europe Androstenedione Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Androstenedione Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Androstenedione Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Androstenedione Market Share by Country (2021-2026) Table 164. Europe Androstenedione Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Androstenedione Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Androstenedione Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Androstenedione Sales by Country (2021-2026) & (MT) Table 168. Asia-Pacific Androstenedione Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Androstenedione Sales Forecast by Country (2027-2032) & (MT) Table 170. Asia-Pacific Androstenedione Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Androstenedione Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Androstenedione Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Androstenedione Market Share by Country (2021-2026) Table 174. Asia-Pacific Androstenedione Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Androstenedione Market Share Forecast by Country (2027-2032) Table 176. Latin America Androstenedione Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 177. Latin America Androstenedione Sales by Country (2021-2026) & (MT) Table 178. Latin America Androstenedione Sales Market Share by Country (2021-2026) Table 179. Latin America Androstenedione Sales Forecast by Country (2027-2032) & (MT) Table 180. Latin America Androstenedione Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Androstenedione Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Androstenedione Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Androstenedione Market Share by Country (2021-2026) Table 184. Latin America Androstenedione Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Androstenedione Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Androstenedione Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Androstenedione Sales by Country (2021-2026) & (MT) Table 188. Middle East and Africa Androstenedione Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Androstenedione Sales Forecast by Country (2027-2032) & (MT) Table 190. Middle East and Africa Androstenedione Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Androstenedione Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Androstenedione Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Androstenedione Market Share by Country (2021-2026) Table 194. Middle East and Africa Androstenedione Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Androstenedione Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Androstenedione Distributors List Table 199. Androstenedione Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Androstenedione Image Figure 2. Global Androstenedione Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Androstenedione Market Size (2021-2032) & (US$ Million) Figure 4. Global Androstenedione Sales (2021-2032) & (MT) Figure 5. Androstenedione Image Figure 6. Global Androstenedione Sales YoY Growth (2021-2032) & (MT) Figure 7. Androstadienedione Image Figure 8. Global Androstadienedione Sales YoY Growth (2021-2032) & (MT) Figure 9. Global Androstenedione Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Androstenedione Market Share by Type 2025 VS 2032 Figure 11. North America Androstenedione Sales Market Share in Volume by Type in 2025 Figure 12. North America Androstenedione Sales Market Share in Value by Type in 2025 Figure 13. Europe Androstenedione Sales Market Share in Volume by Type in 2025 Figure 14. Europe Androstenedione Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Androstenedione Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Androstenedione Sales Market Share in Value by Type in 2025 Figure 17. Latin America Androstenedione Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Androstenedione Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Androstenedione Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Androstenedione Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Androstenedione Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Arthritis Pharmaceuticals Image Figure 24. Global Arthritis Pharmaceuticals Sales YoY Growth (2021-2032) & (MT) Figure 25. Fertility Control Pharmaceuticals Image Figure 26. Global Fertility Control Pharmaceuticals Sales YoY Growth (2021-2032) & (MT) Figure 27. Infectious Inflammation Pharmaceuticals Image Figure 28. Global Infectious Inflammation Pharmaceuticals Sales YoY Growth (2021-2032) & (MT) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (MT) Figure 31. Global Androstenedione Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Androstenedione Market Share by Application 2025 VS 2032 Figure 33. North America Androstenedione Sales Market Share in Volume by Application in 2025 Figure 34. North America Androstenedione Sales Market Share in Value by Application in 2025 Figure 35. Europe Androstenedione Sales Market Share in Volume by Application in 2025 Figure 36. Europe Androstenedione Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Androstenedione Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Androstenedione Sales Market Share in Value by Application in 2025 Figure 39. Latin America Androstenedione Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Androstenedione Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Androstenedione Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Androstenedione Sales Market Share in Value by Application in 2025 Figure 43. North America Androstenedione Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 44. North America Androstenedione Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Androstenedione Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Androstenedione Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Androstenedione Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 48. Europe Androstenedione Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Androstenedione Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Androstenedione Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Androstenedione Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 52. Asia-Pacific Androstenedione Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Androstenedione Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Androstenedione Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Androstenedione Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 56. Latin America Androstenedione Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Androstenedione Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Androstenedione Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Androstenedione Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 60. Middle East and Africa Androstenedione Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Androstenedione Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Androstenedione Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Androstenedione Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Androstenedione Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Androstenedione
  • Androstadienedione
Applications
  • Arthritis Pharmaceuticals
  • Fertility Control Pharmaceuticals
  • Infectious Inflammation Pharmaceuticals
  • Others
Companies covered
  • BIOVET
  • Indo Phyto Chemicals
  • Sito Bio
  • Goto Pharmaceutical
  • Tianjin King York
  • Jiufu
  • Yongning Pharma
  • Jiangxi Hongyuan Pharmaceutical
  • Kaizon
  • Xi’an Gaoyuan Bio-Chem
  • Dongyao Pharmaceutical
  • Huazhong Pharmaceutical
  • Darui
  • Danjiangkou Danao
  • Dahua Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Androstenedione Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Androstenedione Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Androstenedione Market by Type
  6. 1.3.1 Androstenedione
  7. 1.3.2 Androstadienedione
  8. 1.4 Global Androstenedione Market Size by Type
  9. 1.4.1 Global Androstenedione Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Androstenedione Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Androstenedione Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Androstenedione Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Androstenedione Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Androstenedione Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Androstenedione Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Androstenedione Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Androstenedione Industry Trends
  2. 2.2 Androstenedione Industry Drivers
  3. 2.3 Androstenedione Industry Opportunities and Challenges
  4. 2.4 Androstenedione Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Androstenedione Revenue (2021-2026)
  2. 3.2 Global Top Players by Androstenedione Sales (2021-2026)
  3. 3.3 Global Top Players by Androstenedione Price (2021-2026)
  4. 3.4 Global Androstenedione Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Androstenedione Major Company Production Sites & Headquarters
  6. 3.6 Global Androstenedione Company, Product Type & Application
  7. 3.7 Global Androstenedione Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Androstenedione Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Androstenedione Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Androstenedione Tier 1, Tier 2, and Tier 3
4 Androstenedione Regional Status and Outlook
  1. 4.1 Global Androstenedione Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Androstenedione Historic Market Size by Region
  3. 4.2.1 Global Androstenedione Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Androstenedione Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Androstenedione Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Androstenedione Forecasted Market Size by Region
  7. 4.3.1 Global Androstenedione Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Androstenedione Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Androstenedione Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Androstenedione by Application
  1. 5.1 Androstenedione Market by Application
  2. 5.1.1 Arthritis Pharmaceuticals
  3. 5.1.2 Fertility Control Pharmaceuticals
  4. 5.1.3 Infectious Inflammation Pharmaceuticals
  5. 5.1.4 Others
  6. 5.2 Global Androstenedione Market Size by Application
  7. 5.2.1 Global Androstenedione Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Androstenedione Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Androstenedione Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Androstenedione Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Androstenedione Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Androstenedione Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Androstenedione Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Androstenedione Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BIOVET
  2. 6.1.1 BIOVET Company Information
  3. 6.1.2 BIOVET Business Overview
  4. 6.1.3 BIOVET Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BIOVET Androstenedione Product Portfolio
  6. 6.1.5 BIOVET Recent Developments
  7. 6.2 Indo Phyto Chemicals
  8. 6.2.1 Indo Phyto Chemicals Company Information
  9. 6.2.2 Indo Phyto Chemicals Business Overview
  10. 6.2.3 Indo Phyto Chemicals Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Indo Phyto Chemicals Androstenedione Product Portfolio
  12. 6.2.5 Indo Phyto Chemicals Recent Developments
  13. 6.3 Sito Bio
  14. 6.3.1 Sito Bio Company Information
  15. 6.3.2 Sito Bio Business Overview
  16. 6.3.3 Sito Bio Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sito Bio Androstenedione Product Portfolio
  18. 6.3.5 Sito Bio Recent Developments
  19. 6.4 Goto Pharmaceutical
  20. 6.4.1 Goto Pharmaceutical Company Information
  21. 6.4.2 Goto Pharmaceutical Business Overview
  22. 6.4.3 Goto Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Goto Pharmaceutical Androstenedione Product Portfolio
  24. 6.4.5 Goto Pharmaceutical Recent Developments
  25. 6.5 Tianjin King York
  26. 6.5.1 Tianjin King York Company Information
  27. 6.5.2 Tianjin King York Business Overview
  28. 6.5.3 Tianjin King York Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Tianjin King York Androstenedione Product Portfolio
  30. 6.5.5 Tianjin King York Recent Developments
  31. 6.6 Jiufu
  32. 6.6.1 Jiufu Company Information
  33. 6.6.2 Jiufu Business Overview
  34. 6.6.3 Jiufu Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiufu Androstenedione Product Portfolio
  36. 6.6.5 Jiufu Recent Developments
  37. 6.7 Yongning Pharma
  38. 6.7.1 Yongning Pharma Company Information
  39. 6.7.2 Yongning Pharma Business Overview
  40. 6.7.3 Yongning Pharma Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Yongning Pharma Androstenedione Product Portfolio
  42. 6.7.5 Yongning Pharma Recent Developments
  43. 6.8 Jiangxi Hongyuan Pharmaceutical
  44. 6.8.1 Jiangxi Hongyuan Pharmaceutical Company Information
  45. 6.8.2 Jiangxi Hongyuan Pharmaceutical Business Overview
  46. 6.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio
  48. 6.8.5 Jiangxi Hongyuan Pharmaceutical Recent Developments
  49. 6.9 Kaizon
  50. 6.9.1 Kaizon Company Information
  51. 6.9.2 Kaizon Business Overview
  52. 6.9.3 Kaizon Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Kaizon Androstenedione Product Portfolio
  54. 6.9.5 Kaizon Recent Developments
  55. 6.10 Xi’an Gaoyuan Bio-Chem
  56. 6.10.1 Xi’an Gaoyuan Bio-Chem Company Information
  57. 6.10.2 Xi’an Gaoyuan Bio-Chem Business Overview
  58. 6.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio
  60. 6.10.5 Xi’an Gaoyuan Bio-Chem Recent Developments
  61. 6.11 Dongyao Pharmaceutical
  62. 6.11.1 Dongyao Pharmaceutical Company Information
  63. 6.11.2 Dongyao Pharmaceutical Business Overview
  64. 6.11.3 Dongyao Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Dongyao Pharmaceutical Androstenedione Product Portfolio
  66. 6.11.5 Dongyao Pharmaceutical Recent Developments
  67. 6.12 Huazhong Pharmaceutical
  68. 6.12.1 Huazhong Pharmaceutical Company Information
  69. 6.12.2 Huazhong Pharmaceutical Business Overview
  70. 6.12.3 Huazhong Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Huazhong Pharmaceutical Androstenedione Product Portfolio
  72. 6.12.5 Huazhong Pharmaceutical Recent Developments
  73. 6.13 Darui
  74. 6.13.1 Darui Company Information
  75. 6.13.2 Darui Business Overview
  76. 6.13.3 Darui Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Darui Androstenedione Product Portfolio
  78. 6.13.5 Darui Recent Developments
  79. 6.14 Danjiangkou Danao
  80. 6.14.1 Danjiangkou Danao Company Information
  81. 6.14.2 Danjiangkou Danao Business Overview
  82. 6.14.3 Danjiangkou Danao Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Danjiangkou Danao Androstenedione Product Portfolio
  84. 6.14.5 Danjiangkou Danao Recent Developments
  85. 6.15 Dahua Pharmaceutical
  86. 6.15.1 Dahua Pharmaceutical Company Information
  87. 6.15.2 Dahua Pharmaceutical Business Overview
  88. 6.15.3 Dahua Pharmaceutical Androstenedione Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dahua Pharmaceutical Androstenedione Product Portfolio
  90. 6.15.5 Dahua Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Androstenedione Sales by Country
  2. 7.1.1 North America Androstenedione Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Androstenedione Sales by Country (2021-2026)
  4. 7.1.3 North America Androstenedione Sales Forecast by Country (2027-2032)
  5. 7.2 North America Androstenedione Market Size by Country
  6. 7.2.1 North America Androstenedione Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Androstenedione Market Size by Country (2021-2026)
  8. 7.2.3 North America Androstenedione Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Androstenedione Sales by Country
  2. 8.1.1 Europe Androstenedione Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Androstenedione Sales by Country (2021-2026)
  4. 8.1.3 Europe Androstenedione Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Androstenedione Market Size by Country
  6. 8.2.1 Europe Androstenedione Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Androstenedione Market Size by Country (2021-2026)
  8. 8.2.3 Europe Androstenedione Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Androstenedione Sales by Country
  2. 9.1.1 Asia-Pacific Androstenedione Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Androstenedione Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Androstenedione Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Androstenedione Market Size by Country
  6. 9.2.1 Asia-Pacific Androstenedione Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Androstenedione Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Androstenedione Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Androstenedione Sales by Country
  2. 10.1.1 South America Androstenedione Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Androstenedione Sales by Country (2021-2026)
  4. 10.1.3 South America Androstenedione Sales Forecast by Country (2027-2032)
  5. 10.2 South America Androstenedione Market Size by Country
  6. 10.2.1 South America Androstenedione Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Androstenedione Market Size by Country (2021-2026)
  8. 10.2.3 South America Androstenedione Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Androstenedione Sales by Country
  2. 11.1.1 Middle East and Africa Androstenedione Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Androstenedione Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Androstenedione Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Androstenedione Market Size by Country
  6. 11.2.1 Middle East and Africa Androstenedione Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Androstenedione Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Androstenedione Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Androstenedione Value Chain Analysis
  2. 12.1.1 Androstenedione Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Androstenedione Production Mode & Process
  7. 12.2 Androstenedione Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Androstenedione Distributors
  10. 12.2.3 Androstenedione Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst